Newsroom | 12087 results

Sorted by: Latest

Surgery
-

STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the fourth quarter and fiscal year ended January 2, 2026, on Tuesday, March 3 after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress. Event: STAAR S...
-

Resolute Dermatology, LLC Joins Epiphany Dermatology

AUSTIN, Texas--(BUSINESS WIRE)--Epiphany Dermatology announced today it has expanded its presence in Kansas through its partnership with Resolute Dermatology, LLC....
-

OSSIOfiber® Minimally Invasive All-Natural Bunion Correction System Improves, Simplifies Surgical Procedure for Patients and Physicians

TAMPA, Fla.--(BUSINESS WIRE)--With the launch today of OSSIOfiber® Minimally Invasive All-natural (MIA) Bunion Correction System, OSSIO Inc. — a fast-growing medical technology company focused on advancing orthopedic surgery with bio-integrative, metal-free fixation implants — takes a major step forward in perfecting bunionectomy for surgeons and patients and significantly expands its footprint in a fast-growing multimillion-dollar industry. As with all OSSIOfiber implants, the 4.5x70mm beveled...
-

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating Officer, will provide a company overview and update on Monday, March 2, 2026, from 2:30 to 3:00 p.m. EST, at the TD Cowen 46th Annual Health Care Conference in Boston. The presentation can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. An arch...
-

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30 a.m. EST. A live webcast of the fireside chat will be accessible through the Investor Relations page of the Cerus website at http://www.cerus.com/ir. A replay will be available for 90 days after the event. ABOUT CERUS Cerus Corporation is dedicated solely to safe...
-

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and P...
-

Fertility & Surgical Associates of California (FSAC) Opens New Thousand Oaks Facility

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Fertility & Surgical Associates of California has opened its new, custom-built facility at 225 W. Hillcrest Drive, Suite 201 in Thousand Oaks....
-

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2025. Recent Business Highlights Endocardial Catheter AF Ablation Highlighted 100% procedural success, or freedom from atrial fibrillation (AF), at 6 months and 96% procedural success a...
-

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

SAN ANTONIO, Texas--(BUSINESS WIRE)--In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a CT scan....
-

United Aesthetics Alliance Announces Partnership With LivSkin MedSpa | Laser

MINNEAPOLIS--(BUSINESS WIRE)--United Aesthetics Alliance (“UAA” or the “Company”), a leading platform of plastic surgery practices and medical spa brands, today announced its partnership with LivSkin MedSpa | Laser (“LivSkin”), a medical spa industry leader in anti-aging products and procedures based in Minneapolis. The transaction represents a significant strategic acquisition that further strengthens UAA’s presence in the Minneapolis–St. Paul metropolitan area, complementing Edina Plastic Sur...